​

Funding Round

Series B - Noema Pharma

Series B - Noema Pharma

Investment Firm

Overview

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Announced Date

Mar 07, 2023

Closed on Date

Mar 07, 2023

Funding Type

Series B

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Jeito Capital

Jeito Capital

Jeito Capital is a early_stage_venture and late_stage_venture firm.

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners is a early_stage_venture and post_ipo and seed firm.

Participant Investors

6

Investor Name
Participant InvestorJeito Capital
Participant InvestorSofinnova Partners
Participant InvestorGilde Healthcare
Participant InvestorInvus
Participant InvestorPolaris Partners

Round Details and Background

Noema Pharma raised $109304463 on 2023-03-07 in Series B

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2020
Series A - Noema Pharma
5-60.0M
Mar 07, 2023
Series B - Noema Pharma
7-109.3M

Recent Activity

There is no recent news or activity for this profile.